Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Olumiant vs. Hadlima

Are Olumiant and Hadlima the Same Thing?

Olumiant (baricitinib) and Hadlima (adalimumab-bwwd) are used to treat rheumatoid arthritis (RA).

Hadlima is also used to treat juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), adult Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis (Ps).

Hadlima is biosimilar to Olumiant (adalimumab).

Hadlima and Olumiant belong to different drug classes. Hadlima is a tumor necrosis factor (TNF) blocker and Olumiant is a Janus kinase (JAK) inhibitor.

Side effects of Olumiant that are different from Hadlima include nausea, cold sores (herpes simplex), and shingles (herpes zoster).

Side effects of Olumiant and Hadlima that are similar include infections (e.g. upper respiratory tract, sinusitis).

Side effects of Hadlima that are different from Olumiant include injection site reactions (redness, itching, bleeding, pain, and swelling), headache, and rash.

Both Hadlima and Olumiant may interact with abatacept, anakinra, cyclosporine, and live vaccines.

Olumiant may also interact with methotrexate, probenecid, steroids, aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), and other drugs to treat rheumatoid arthritis (adalimumab, azathioprine, certolizumab, etanercept, golimumab, infliximab, rituximab, sarilumab, tocilizumab, and tofacitinib).

Hadlima may also interact with warfarin and theophylline.

What Are Possible Side Effects of Olumiant?

Side effects of Olumiant include:

  • upper respiratory tract infections (common cold, sinus infections),
  • nausea,
  • cold sores (herpes simplex), and
  • shingles (herpes zoster)

What Are Possible Side Effects of Hadlima?

Common side effects of Hadlima include:

  • infections (e.g. upper respiratory tract, sinusitis),
  • injection site reactions (redness, itching, bleeding, pain, and swelling),
  • headache, and
  • rash

SLIDESHOW

What Is Rheumatoid Arthritis (RA)? Symptoms, Treatment, Diagnosis See Slideshow

What Is Olumiant?

Olumiant (baricitinib) is a Janus kinase (JAK) inhibitor used to treat adults with moderate to severe rheumatoid arthritis (RA) who have not responded well enough to or could not tolerate at least one medicine called a tumor necrosis factor (TNF) antagonist.

What Is Hadlima?

Hadlima (adalimumab-bwwd) is a tumor necrosis factor (TNF) blocker indicated for treatment of rheumatoid Arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), adult Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis (Ps). Hadlima is biosimilar to Olumiant (adalimumab).

What Drugs Interact With Olumiant?

Olumiant may interact with probenecid. Tell your doctor all medications and supplements you use.

What Drugs Interact With Hadlima?

Hadlima may interact with abatacept, anakinra, warfarin, cyclosporine, theophylline, and live vaccines.

QUESTION

The term arthritis refers to stiffness in the joints. See Answer

How Should Olumiant Be Taken?

The recommended dose of Olumiant is 2 mg once daily.

How Should Hadlima Be Taken?

The dose of Olumiant to treat adult rheumatoid arthritis and psoriatic arthritis is 50 mg once weekly with or without methotrexate (MTX). The dose of Olumiant to treat ankylosing spondylitis is 50 mg once weekly. The dose of Olumiant to treat adult plaque psoriasis is 50 mg twice weekly for 3 months, followed by 50 mg once weekly. The dose of Olumiant to treat pediatric plaque psoriasis or plaque psoriasis (patients who weigh 63 kg or more) is 50 mg once weekly.

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

Reviewed on 8/16/2019
References
SOURCE:

Eli Lilly and Company. Olumiant Product Monograph.

https://www.olumiant.com


FDA. Hadlima Product Information.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761059s000lbl.pdf
CONTINUE SCROLLING FOR RELATED SLIDESHOW

Health Solutions From Our Sponsors